BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6282445)

  • 1. Similarities in the formation and removal of covalent DNA adducts in benzo(a)pyrene-treated BALB/3T3 variant cells with different induced transformation frequencies.
    Lo KY; Kakunaga T
    Cancer Res; 1982 Jul; 42(7):2644-50. PubMed ID: 6282445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzo(a)pyrene-DNA adduct formation and removal in mouse epidermis in vivo and in vitro: relationship of DNA binding to initiation of skin carcinogenesis.
    Nakayama J; Yuspa SH; Poirier MC
    Cancer Res; 1984 Sep; 44(9):4087-95. PubMed ID: 6331664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formation and persistence of DNA, RNA, and protein adducts in mouse skin exposed to pure optical enantiomers of 7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyre ne in vivo.
    Pelling JC; Slaga TJ; DiGiovanni J
    Cancer Res; 1984 Mar; 44(3):1081-6. PubMed ID: 6198079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of (7S,8R)-dihydroxy-(9R,10S)-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene adducts in human serum albumin by laser-induced fluorescence: implications for the in vivo metabolism of benzo[a]pyrene.
    Ozbal CC; Skipper PL; Yu MC; London SJ; Dasari RR; Tannenbaum SR
    Cancer Epidemiol Biomarkers Prev; 2000 Jul; 9(7):733-9. PubMed ID: 10919745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of benzo(a)pyrene metabolite:DNA adducts in lung and liver of mice.
    Kulkarni MS; Anderson MW
    Cancer Res; 1984 Jan; 44(1):97-101. PubMed ID: 6317174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-response relationships for the binding of benzo(a)pyrene metabolites to DNA and protein in lung, liver, and forestomach of control and butylated hydroxyanisole-treated mice.
    Adriaenssens PI; White CM; Anderson MW
    Cancer Res; 1983 Aug; 43(8):3712-9. PubMed ID: 6305492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formation of benzo(a)pyrene/DNA adducts and their relationship to tumor initiation in mouse epidermis.
    Ashurst SW; Cohen GM; Nesnow S; DiGiovanni J; Slaga TJ
    Cancer Res; 1983 Mar; 43(3):1024-9. PubMed ID: 6297716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitation of benzo(a)pyrene-deoxyguanosine adducts by radioimmunoassay.
    Poirier MC; Santella R; Weinstein IB; Grunberger D; Yuspa SH
    Cancer Res; 1980 Feb; 40(2):412-6. PubMed ID: 7356524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of benzo(a)pyrene:DNA adducts formed in cells in culture by immobilized boronate chromatography.
    Pruess-Schwartz D; Sebti SM; Gilham PT; Baird WM
    Cancer Res; 1984 Sep; 44(9):4104-10. PubMed ID: 6331665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of benzo(a)pyrene and benzo(a)pyrene-trans-7,8-diol metabolism and DNA binding in mouse lung explants by ellagic acid.
    Dixit R; Teel RW; Daniel FB; Stoner GD
    Cancer Res; 1985 Jul; 45(7):2951-6. PubMed ID: 4039974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin endoperoxide synthetase-dependent cooxidation of (+/-)-trans-7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene in C3H/10T 1/2 clone 8 cells.
    Boyd JA; Barrett JC; Eling TE
    Cancer Res; 1982 Jul; 42(7):2628-32. PubMed ID: 6805944
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of butylated hydroxyanisole, alpha-angelica lactone, and beta-naphthoflavone on benzo(alpha)pyrene:DNA adduct formation in vivo in the forestomach, lung, and liver of mice.
    Ioannou YM; Wilson AG; Anderson MW
    Cancer Res; 1982 Apr; 42(4):1199-204. PubMed ID: 7059996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential removal of DNA adducts derived from anti-diol epoxides of dibenzo[a,l]pyrene and benzo[a]pyrene in human cells.
    Dreij K; Seidel A; Jernström B
    Chem Res Toxicol; 2005 Apr; 18(4):655-64. PubMed ID: 15833025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of 5-azacytidine on malignant transformation of a mutant derived from the mouse BALB/c 3T3 cell line resistant to transformation by chemical carcinogens.
    Yasutake C; Kuratomi Y; Ono M; Masumi S; Kuwano M
    Cancer Res; 1987 Sep; 47(18):4894-9. PubMed ID: 2441855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of aspirin and indomethacin on the formation of benzo(a)pyrene-induced pulmonary adenomas and DNA adducts in A/HeJ mice.
    Adriaenssens PI; Sivarajah K; Boorman GA; Eling TE; Anderson MW
    Cancer Res; 1983 Oct; 43(10):4762-7. PubMed ID: 6309376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitation of benzo(a)pyrene metabolite: DNA adducts in selected hepatic and pulmonary cell types isolated from [3H]benzo(a)pyrene-treated rabbits.
    Horton JK; Rosenior JC; Bend JR; Anderson MW
    Cancer Res; 1985 Aug; 45(8):3477-81. PubMed ID: 3926299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-performance liquid chromatography electrospray ionization tandem mass spectrometry for the detection and quantitation of benzo[a]pyrene-DNA adducts.
    Beland FA; Churchwell MI; Von Tungeln LS; Chen S; Fu PP; Culp SJ; Schoket B; Gyorffy E; Minárovits J; Poirier MC; Bowman ED; Weston A; Doerge DR
    Chem Res Toxicol; 2005 Aug; 18(8):1306-15. PubMed ID: 16097804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intercellular communication capacity as a possible determinant of transformation sensitivity of BALB/c 3T3 clonal cells.
    Yamasaki H; Enomoto T; Shiba Y; Kanno Y; Kakunaga T
    Cancer Res; 1985 Feb; 45(2):637-41. PubMed ID: 3967239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of invasive and experimental metastasis potential in BALB/c 3T3 cells by benzo(a)pyrene transformation.
    Melchiori A; Colacci A; Lollini PL; De Giovanni C; Carlone S; Grilli S; Parodi S; Albini A
    Invasion Metastasis; 1992; 12(1):1-11. PubMed ID: 1512133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of visible light on benzo(a)pyrene binding to DNA of cultured human skin epithelial cells.
    Camalier RF; Gantt R; Price FM; Stephens EV; Baeck AE; Taylor WG; Sanford KK
    Cancer Res; 1981 May; 41(5):1789-93. PubMed ID: 6260352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.